Belmont, MA, United States of America

Bing Yu

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 24(Granted Patents)


Location History:

  • Ambler, PA (US) (2013)
  • Cambridge, MA (US) (2015 - 2018)
  • Belmont, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Exploring the Innovations of Inventor Bing Yu

Introduction: Bing Yu is a distinguished inventor based in Belmont, MA, USA, recognized for his contributions to the field of pharmaceuticals with a total of 11 patents. His work primarily focuses on the development of compounds that inhibit specific biological activities, which has significant implications for the management of various diseases.

Latest Patents: Among his latest innovations, Yu has developed notable patents that pertain to compounds and compositions for inhibiting the activity of SHP2. The compounds outlined in his inventions are characterized by a specific formula and demonstrate the capability to inhibit SHP2 activity effectively. Furthermore, his inventions include processes for preparing these compounds, as well as pharmaceutical preparations that incorporate them. The methods of using these compounds are particularly aimed at managing diseases or disorders associated with the aberrant activity of SHP2.

Career Highlights: Throughout his career, Bing Yu has made remarkable strides within the pharmaceutical industry, demonstrating a consistent commitment to innovation. As a member of the team at Novartis AG, he has played a crucial role in advancing therapeutic solutions that address significant medical challenges. His extensive patent portfolio underscores his expertise and dedication to research and development.

Collaborations: In his endeavors, Yu has collaborated with talented professionals, including Heather Elizabeth Burks and Michael A Dechantsreiter. Together, they contribute to the collaborative environment that fosters innovation within Novartis AG, allowing for the exchange of ideas and the development of groundbreaking solutions in the healthcare sector.

Conclusion: Bing Yu exemplifies the spirit of innovation in the pharmaceutical arena. His dedicated work on compounds that inhibit SHP2 activity not only highlights his inventiveness but also reflects his commitment to improving health outcomes. With a robust portfolio of patents and ongoing collaborations, Yu is poised to continue making significant contributions to the field of medicines and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…